Skip to content

High Tone Power Therapy Versus Transcutanuoselectrical Nerve Stimulation on Polyneuropathic Pain in Diabetic Patients

High Tone Power Therapy Versus Transcutanuoselectrical Nerve Stimulation on Polyneuropathic Pain in Diabetic Patients

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06822218
Enrollment
60
Registered
2025-02-12
Start date
2023-01-01
Completion date
2025-02-28
Last updated
2025-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabete Mellitus

Brief summary

the results of this study may provide an easy non pharmacological modality for dealing with diabetic polyneuropathic pain. Also, the outcome of this study will guide physiotherapists to develop a new noninvasive treatment modality that may improve patient symptoms and promotes their social participation , this in turn may add to clinical role played by therapists in management of diabetic polyneuropathy. In Addition, increased knowledge of the influence of High tone power therapy on neuropathic pain

Detailed description

This study will be carried out on sixty diabetic male patients with polyneuropathy with ages 50-60 years . Patient will be randomly assigned to two grouos. group A will include 30 type 2 diabetic patients with diabetic polyneuropathy. Theses patients will receive High tone power therapy with Frequencies continuously will be scanned from 4096 Hz to 31768 Hz, allowing for a much higher power of up to 5000 mW to be introduced for 3 times per week, for 3 months for 30 minutes every session. Group B : This group will include 30 type 2 diabetic patients with diabetic neuropathy. These patients will receive TENS with applied frequencies range from 2 to 120 Hz. for 3 times per week for 30 minutes every session during 3 months of intervention.

Interventions

patients will be assigned into 2 groups with pre and post treatment protocol application. all patients will be thoroughly evaluated before and after treatment protocol application.

DEVICETENS

These patients will receive TENS with applied frequencies range from 2 to 120 Hz. for 3 times per week for 30 minutes every session during 3 months of intervention in addition to medications.

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
50 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* The patient selection will be according to the following criteria: 1. Sixty male patients are diagnosed with diabetic polyneuropathy their ages will be ranged from 50-60 years old. 2. All patients are ambulant independently. 3. All patients are under full medical control 4. HbA1c is ranged from 6.5 : 7 %. 5. Patients has diabetes more than 10 years.

Exclusion criteria

* The participants will be excluded if they meet one of the following criteria: 1. Psychiatric disorders or seizures. 2. Visual and auditory impairment or tremors influencing balance. 3. Other neuromuscular disorders. 4. Foot deformities and ulcers. 5. Lower limb operations. 6. Feverish systemic infection 7. cardiac pacemaker.

Design outcomes

Primary

MeasureTime frameDescription
Neuropathic pain by DN4 (Douleur Neuropathique en 4 Questions) Questions)up to 12 weekst is a questionnaire has been developed to facilitate detection of neuropathic pain.total score is 10 .diagnosis of neuropathic pain is 4/10.
Pain pressure threshold algometerup to 12 weeksdevices that can be used to identify the pressure and/or force eliciting a pressure-pain threshold. It has been noted in pressure

Secondary

MeasureTime frameDescription
Glyclated Haemoglobin Level (HbA1c)up to 12 weeksIncreasing HbA1c level is significantly associated with increased prevalence of DPN as well as PDPN and non-painful DPN
life disabilityup to 12 weeksthe World Health Organization Quality of Life Brief Version (WHOQOL-BREF) is an abbreviated, 26-item version of the 100-item WHOQOL-100 quality of life measure. The WHOQOL-BREF addresses four quality of life domains: physical health, psychological health, social relationships and environment. Then calculate a domain score for each of the health domains by calculating the average answer points for each domain (sum of answer points divided by number of questions) and multiplying the result by the number 4.

Countries

Egypt

Contacts

Primary Contactzeinab Awadallah, master
zeezee.awad88@hotmail.com+201285819342
Backup ContactAlaa El-Moatasem, lecturer
alaamotasem@rocketmail.com01006625054

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026